Shin Nippon Biomedical Laboratories, Takeda Pharmaceutical Successfully Complete Joint Research on Cynomolgus Monkey.
Since 2002, the two companies have collaborated in the search and analysis of organ-specific virulence-associated genes of cynomolgus ("crab-eating") monkeys. The aim of this collaboration is to develop an effective tool for analyzing and estimating the toxicity of drug candidates.
Through the four-year collaboration, the partners have analyzed genes expressed in the six main organs of cynomolgus monkeys and established a database that covers the entire genome sequences of cynomolgus monkey.
Further, they have created a customized DNA microarray that mounts representative sequences from 15,000 genes. Subsequently, they have confirmed that the customized DNA microarray can be used to evaluate toxicity in primates. Further, they have developed a gene expression database for 27 organs used in toxicity analysis.
Details of the joint research were presented at the 46th Annual Meeting of the Society of Toxicology and will be presented at the 33rd Annual Meeting of the Japanese Society of Toxicology, to be held in Nagoya in July.
Going forward, SNBL plans to proceed with research and aims to develop an innovative tool for toxicity analysis of drug candidates.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Jun 27, 2006|
|Previous Article:||Pfizer Japan Surveys Smokers.|
|Next Article:||Teijin Pharma, Sato Pharmaceutical Jointly Introduce Antipsoriatic Agent Bonalfa.|